Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$9.14 USD
-0.07 (-0.76%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $9.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Adherex Technologies Inc. [FENC]
Reports for Purchase
Showing records 61 - 80 ( 102 total )
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
FY19 Financials; Awaiting FDA Action Following NDA Submission
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Regulatory Submission Complete; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Rolling NDA Submission Complete; Approval Anticipated in Q3:20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Application Submission Nearing Completion; 3Q19 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
HEALTHCARE - 2019 PacGrow Healthcare Conference: Day 2 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
2Q19 Financial Results Reported; PEDMARK Regulatory Submission Completion in Early 2020; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
1Q19 Financial Results Reported; PEDMARK Filing Completion Near Term; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
FY18; Manufacturing Hiccup to Delay NDA Approval, but Opportunity Unchanged
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
FY2018 Financial Results Reported; PEDMARK Filing Timeline Update; Modulating Target to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Termination of Coverage - Analyst(s) Departure
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Term Loan Facility Obtained; PEDMARK Filing Completion Approaches; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK U.S. Market Entry Expected in Summer 2019; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
FENC Initiates Rolling NDA with Broad Label for PEDMARK
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D